An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
Brings 25 years of global operations and supply chain experience to Piramal
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
Bringing next-gen cannabinoid therapeutics to cancer patients
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Both manufacturing facilities are based out of Benguluru, India
Subscribe To Our Newsletter & Stay Updated
